by Ismail Amin | Mar 13, 2023 | Business Law, News
Federal Reserve and the Exchange Stabilization Fund Silicon Valley Bank’s failure will be scrutinized and is somewhat unique due to its exposure to tech start-ups. Signature Bank was known for exposure to the Crypto markets. In response to the failures, the Federal...
by Ismail Amin | Mar 6, 2023 | artificial intelligence, Biotech Bulletin, Business Law, Healthcare, Life Sciences, News
On March 1, 2023, the FDA’s Center for Drug Evaluation and Research (CDER) issued a discussion paper on the role of Artificial Intelligence (AI) in the context of drug manufacturing and the implications for “measurement, modeling, and control technologies used in...
by Ismail Amin | Sep 29, 2022 | Biotech Bulletin, News
While many biotech and life-science companies have impeccable products and intellectual property pipelines, they are often in need of appropriate capital to execute the company’s mission. There are numerous ways to raise capital, from many different markets (private...
by Ismail Amin | Sep 27, 2022 | News, Securities
In a landmark crypto-currency litigation case pending before the US District Court in the Southern District of New York, the Securities and Exchange Commission (“SEC”) brought an action against Ripple Labs, Inc. and its officers (“Ripple”). The crux of the SEC’s...
by Ismail Amin | Aug 24, 2022 | Biotech Bulletin, News
In the second part of the clinical trials series, we examine the duties and obligations of Sponsors and Clinical Research Organizations (CRO) as it relates to the protection of human subjects who participate in clinical trials. Generally, a “Human Subject” is an...